Recent advances in treatment of follicular lymphoma: efficacy of PI3Kα/δ inhibitor (TQ-B3525)  

作　　者：Takuya Watanabe 

机构地区：[1]Department of Internal Medicine and Gastroenterology,Watanabe Internal Medicine Aoyama Clinic,Niigata-city 9502002,Japan

出　　处：《Signal Transduction and Targeted Therapy》2024年第6期2341-2343,共3页信号转导与靶向治疗（英文）

摘　　要：The commented study reports the results of monotherapy using TQ-B3525,a novel phosphatidylinositol-3 kinase(PI3K)inhibitor developed in China,in patients with refractory/relapsed follicular lymphoma(r/r FL).

关 键 词：PI3K LYMPHOMA TREATMENT 

分 类 号：R733.1[医药卫生—肿瘤]